Kalaris Therapeutics, Inc.
KLRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001754068
No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Kalaris Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 77 | 72 | −5 |
| Shares | 49.3M | 46.8M | −2.47M (−5.0%) |
| Value | $36.4M | $33.9M | −$2.48M (−6.8%) |
New holders (15)
Institutions that held Kalaris Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RBF Capital, LLC | 449,014 | $324.8K | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 194,473 | $140.7K | 0.01% |
| Jane Street Group, LLC | 173,031 | $125.2K | 0.00% |
| Centiva Capital, LP | 137,897 | $99.7K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 76,278 | $55.2K | 0.01% |
| Paloma Partners Management Co | 31,765 | $23.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 26,032 | $18.8K | 0.00% |
| Point72 (DIFC) Ltd | 17,227 | $12.5K | 0.00% |
| Balyasny Asset Management LLC | 15,947 | $11.5K | 0.00% |
| Jump Financial, LLC | 14,565 | $10.5K | 0.00% |
| Catalyst Funds Management Pty Ltd | 13,000 | $9.40K | 0.00% |
| IFP Advisors, Inc | 3,000 | $2.17K | 0.00% |
| Macquarie Group Ltd | 2,561 | $1.85K | 0.00% |
| SRS Capital Advisors, Inc. | 451 | $327 | 0.00% |
| Nisa Investment Advisors, LLC | 8 | $6 | 0.00% |
Sold out (20)
Institutions that held Kalaris Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Irenic Capital Management LP | 2,579,582 | $1.95M |
| Bank of New York Mellon Corp | 159,423 | $120.3K |
| Deutsche Bank AG | 70,751 | $53.8K |
| Alliancebernstein L.P. | 64,430 | $48.6K |
| Verition Fund Management LLC | 63,815 | $48.2K |
| Amundi | 45,448 | $33.7K |
| Barclays PLC | 35,247 | $26.6K |
| Capstone Investment Advisors, LLC | 27,250 | $20.6K |
| American International Group, Inc. | 1,153,976 | $19.8K |
| Manufacturers Life Insurance Company, The | 21,345 | $16.1K |
| Principal Financial Group Inc | 20,732 | $15.7K |
| Wells Fargo & Company | 18,263 | $13.8K |
| SG Americas Securities, LLC | 17,584 | $13.0K |
| Invesco Ltd. | 11,912 | $8.99K |
| Legal & General Group Plc | 4,029 | $3.04K |
| Quantbot Technologies LP | 3,259 | $2.46K |
| Ameritas Investment Partners, Inc. | 2,408 | $1.82K |
| Amalgamated Bank | 1,027 | $1.00K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 9 | $6 |
| Mirae Asset Global Investments Co., Ltd. | 12,116 | – |